Cargando…

ESRRG-PKM2 axis reprograms metabolism to suppress esophageal squamous carcinoma progression and enhance anti-PD-1 therapy efficacy

BACKGROUND: Glycolysis under normoxic conditions, known as the Warburg effect, confers a selective advantage for the survival and proliferation of many tumors. In this study, we investigated the role of estrogen-related receptor gamma (ESRRG) in metabolic reprogramming in esophageal squamous cell ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Tianxiao, Zhu, Yongjun, Chen, Lu, Zhang, WenXin, Qi, Huijie, Shi, Xiaojin, Zhong, Mingkang, Chen, Haifei, Li, Qunyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485992/ https://www.ncbi.nlm.nih.gov/pubmed/37679788 http://dx.doi.org/10.1186/s12967-023-04347-5

Ejemplares similares

Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxel-based chemotherapy in breast cancer patients
por: Chen, Lu, et al.
Publicado: (2018)

ESRRG promoter hypermethylation as a diagnostic and prognostic biomarker in laryngeal squamous cell carcinoma
por: Shen, Zhisen, et al.
Publicado: (2019)

RB1 loss triggers dependence on ESRRG in retinoblastoma
por: Field, Matthew G., et al.
Publicado: (2022)

ESRRG, ATP4A, and ATP4B as Diagnostic Biomarkers for Gastric Cancer: A Bioinformatic Analysis Based on Machine Learning
por: Chen, Qiu, et al.
Publicado: (2022)

Sophoridine exerts tumor-suppressive activities via promoting ESRRG-mediated β-catenin degradation in gastric cancer
por: Peng, Zhiyang, et al.
Publicado: (2020)

The discovery of a novel series of potential ERRα inverse agonists based on p-nitrobenzenesulfonamide template for triple-negative breast cancer in vivo
por: Gao, Zhipei, et al.
Publicado: (2021)

ESRRG and PERM1 Govern Mitochondrial Conversion in Brite/Beige Adipocyte Formation
por: Müller, Sebastian, et al.
Publicado: (2020)

Lupus susceptibility gene Esrrg modulates regulatory T cells through mitochondrial metabolism
por: Li, Wei, et al.
Publicado: (2021)

Sex-specific effects of bisphenol A on the signaling pathway of ESRRG in the human placenta
por: Zou, Zhiyong, et al.
Publicado: (2022)

Role of PKM2-Mediated Immunometabolic Reprogramming on Development of Cytokine Storm
por: Liu, Zhijun, et al.
Publicado: (2021)

PKM2: The Thread Linking Energy Metabolism Reprogramming with Epigenetics in Cancer
por: Chen, Ling, et al.
Publicado: (2014)

The mTOR Pathway Regulates PKM2 to Affect Glycolysis in Esophageal Squamous Cell Carcinoma
por: Xiaoyu, He, et al.
Publicado: (2018)

SUMOylation of HSP27 regulates PKM2 to promote esophageal squamous cell carcinoma progression
por: Zhang, Xiao, et al.
Publicado: (2020)

Epigenomic Elements Analyses for Promoters Identify ESRRG as a New Susceptibility Gene for Obesity-related Traits
por: Dong, Shan-Shan, et al.
Publicado: (2016)

Esrrg functions in early branch generation of the ureteric bud and is essential for normal development of the renal papilla
por: Berry, Rachel, et al.
Publicado: (2011)

Placental ESRRG-CYP19A1 Expressions and Circulating 17-Beta Estradiol in IUGR Pregnancies
por: Anelli, Gaia Maria, et al.
Publicado: (2019)

E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing
por: Chen, De, et al.
Publicado: (2020)

Salvianolic Acid B Suppresses Non-Small-Cell Lung Cancer Metastasis through PKM2-Independent Metabolic Reprogramming
por: Zhang, Hong, et al.
Publicado: (2022)

Pkm2 can enhance pluripotency in ESCs and promote somatic cell reprogramming to iPSCs
por: Qin, Shengtang, et al.
Publicado: (2017)

Role of Esrrg in the fibrate-mediated regulation of lipid metabolism genes in human ApoA-I transgenic mice
por: Sanoudou, D, et al.
Publicado: (2009)

The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs
por: Puckett, Dexter L., et al.
Publicado: (2021)

PKM2 Modulation in Head and Neck Squamous Cell Carcinoma
por: Boschert, Verena, et al.
Publicado: (2022)

Upregulated miR‑378a‑3p expression suppresses energy metabolism and promotes apoptosis by targeting a GLUT‑1/ALDOA/PKM2 axis in esophageal carcinoma
por: Qu, Yuan, et al.
Publicado: (2023)

LncRNA NLIPMT Inhibits Tumorigenesis in Esophageal Squamous-Cell Carcinomas by Regulating miR-320/Survivin Axis
por: Li, Demao, et al.
Publicado: (2020)

Influence of estrogen-related receptor γ (ESRRG) rs1890552 A > G polymorphism on changes in fasting glucose and arterial stiffness
por: Kim, Minjoo, et al.
Publicado: (2017)

Suppression of the ERK–SRF axis facilitates somatic cell reprogramming
por: Huh, Sejong, et al.
Publicado: (2018)

FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2
por: Rao, Jianhua, et al.
Publicado: (2022)

LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma
por: Tao, Mingyue, et al.
Publicado: (2021)

PKM2 and cancer: The function of PKM2 beyond glycolysis
por: DONG, GAOCHAO, et al.
Publicado: (2016)

Lactylation of PKM2 Suppresses Inflammatory Metabolic Adaptation in Pro-inflammatory Macrophages
por: Wang, Jizhuang, et al.
Publicado: (2022)

Secreted parasite Pin1 isomerase stabilizes host PKM2 to reprogram host cell metabolism
por: Marsolier, Justine, et al.
Publicado: (2019)

PD-1 Targeted Nanoparticles Inhibit Activated T Cells and Alleviate Autoimmunity via Suppression of Cellular Energy Metabolism Mediated by PKM2
por: Liu, Zhangluxi, et al.
Publicado: (2022)

POLE2 knockdown reduce tumorigenesis in esophageal squamous cells
por: Zhu, Yongjun, et al.
Publicado: (2020)

Knockdown of PKM2 Suppresses Tumor Growth and Invasion in Lung Adenocarcinoma
por: Sun, Hong, et al.
Publicado: (2015)

miR-613 suppresses migration and invasion in esophageal squamous cell carcinoma via the targeting of G6PD
por: Su, Xiangyu, et al.
Publicado: (2020)

PKM and the maintenance of memory
por: Glanzman, David L.
Publicado: (2013)

The success of anti-PD-1 with chemotherapy for esophageal squamous cell carcinoma
por: van Laarhoven, Hanneke W.M., et al.
Publicado: (2023)

LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway
por: Zheng, Yin-Li, et al.
Publicado: (2019)

UCHL1-PKM2 axis dysregulation is associated with promoted proliferation and invasiveness of urothelial bladder cancer cells
por: Zheng, Yuhui, et al.
Publicado: (2023)

PKM2, function and expression and regulation
por: Zhang, Ze, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3rjmvmpo7hd1u7q1qhpr7abvdq